iFabric Corp. Launches Frontline(TM) Clinically Validated Antimicrobial Scrubs at Major Canadian Wholesale Club Retailer

Executive Summary

• iFabric Corp.’s subsidiary Intelligent Fabric Technologies (North America) Inc. (IFTNA) launched Frontline™, a new line of medical scrubs incorporating PROTX2® antimicrobial and ecoPEL™ durable‑water‑repellent technologies, now sold through a major Canadian wholesale club retailer (Costco).
• The launch is backed by a peer‑reviewed clinical study published in the Journal of Hospital Infection that demonstrated statistically significant reductions in surface bacterial contamination on treated scrubs versus untreated controls.
• iFabric highlights this as a “significant commercial milestone,” indicating scalability of its proprietary textile technologies and opening a pathway for broader market penetration in healthcare apparel.

Key Details

• Launch Platform: Frontline™ scrubs are available online via Costco Canada (e‑commerce site).
• Example product URLs:
  • https://www.costco.ca/frontline-womens-two-pocket-v-neck-scrub-top.product.4000369204.html
  • https://www.costco.ca/frontline-womens-scrub-jogger.product.4000425176.html
• Technology Integration: Each garment combines:
• PROTX2® – eco‑friendly antimicrobial and anti‑odor textile treatment.
• ecoPEL™ – fluorine‑free durable water‑repellent (DWR) finish that maintains breathability.
• Clinical Validation: Peer‑reviewed study (Journal of Hospital Infection, 2025) showed statistically significant bacterial reduction on scrubs treated with the PROTX2®/ecoPEL™ combination in real‑world healthcare settings. Full article: https://www.journalofhospitalinfection.com/article/S0195-6701(25)00222-1/fulltext
• Commercial Significance:
• Represents IFTNA’s second major retail adoption of its performance‑apparel technologies.
• Positions IFTNA as an end‑to‑end partner from chemistry development through consumer‑ready product manufacturing at scale.
• Anticipated future expansion to additional product assortments and potentially brick‑and‑mortar distribution, subject to retailer planning and member adoption.
• Executive Commentary:
• Giancarlo Beevis, President & CEO of IFTNA, emphasized the translation of peer‑reviewed clinical evidence into accessible apparel for healthcare professionals, noting the demand for antimicrobial solutions supported by rigorous data.
• Forward‑Looking Statements: The release contains expectations regarding product adoption, market expansion, and performance attributes that are subject to risks and uncertainties.

Notable Quotes

“Frontline™ scrubs translate peer‑reviewed clinical evidence into accessible, everyday apparel built for the realities of modern healthcare – long shifts, frequent laundering, and regular exposure to bacteria from fluids and surfaces,” — Giancarlo Beevis, President & CEO, IFTNA.

“Healthcare professionals have increasingly demanded antimicrobial solutions supported by rigorous clinical data rather than marketing claims alone… positions IFTNA to address what we believe is a substantial and growing demand for clinically‑proven infection control apparel in healthcare settings.” — Giancarlo Beevis.